Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03075202 · ClinicalTrials.gov registry record
Role of an E-cigarette on Smoking Displacement in Smokers With Schizophrenia
A clinical trial, sponsored by Weill Medical College of Cornell University.
- Completed
- Registry status
- 1
- Enrollment target
NCT03075202 is a clinical trial that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 1 participants.
The verdict
NCT03075202 has completed, sponsored by Weill Medical College of Cornell University.
- COMPLETED
- Registry status
- 1 participants
- Enrollment target
Study Summary
It is well established in the scientific literature that people with schizophrenia smoke tobacco cigarettes at rates up to three times that of the general population, relapse more frequently, and die an average of 25 years earlier from cigarette smoking and other life-style attributable illnesses. Electronic cigarettes (e-cigarettes) are becoming increasingly popular with smokers worldwide and new research suggests that e-cigarettes are appealing to smokers with schizophrenia. There is a paucity of research focused on the experience of smokers with schizophrenia who decide to try an e-cigarette. A well-designed prospective-observational study is needed to learn more about the influence of e-cigarette use on cigarette smoking behavior and mental and physical health among smokers with schizophrenia. In response, the investigators have designed a study titled, Role of an electronic cigarette on smoking displacement in smokers with schizophrenia: A prospective 3-month pilot study (SchizEcig).
Interventions
- DEVICE e-cigarette, brand name JUUL
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2017-03-03 |
| Est. Completion | 2018-12-24 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03075202
The ClinicalTrials.gov registry entry for NCT03075202 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which e-cigarette, brand name JUUL is the first listed.
NCT03075202 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03075202 about?
NCT03075202 is a clinical study titled "Role of an E-cigarette on Smoking Displacement in Smokers With Schizophrenia". It is well established in the scientific literature that people with schizophrenia smoke tobacco cigarettes at rates up to three times that of the general population, relapse more frequently, and die an average of 25 years earlier from cigarette smoking and other life-style attributable illnesses. E...
What is the current status of trial NCT03075202?
This trial is currently completed. The enrollment target is 1 participants. The study started on 2017-03-03. Estimated completion is 2018-12-24.
What interventions are being tested in trial NCT03075202?
The interventions under investigation include: e-cigarette, brand name JUUL (DEVICE).
Who is sponsoring clinical trial NCT03075202?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.